OXYGENTAPHLTD logo

Oxygenta Pharmaceutical Ltd

OXYGENTAPHLTD·NSE·
0.00 +0.00 (+0.00%)
Market Cap214.52 Cr
PE Ratio-15.20
Volume
Day High - Low
52W High-Low75.00 - 43.00

Oxygenta Pharmaceutical Ltd (OXYGENTAPHLTD): company summary

Oxygenta Pharmaceutical Ltd (OXYGENTAPHLTD) is a micro-cap Healthcare company valued at ₹215 crore operating in Pharmaceuticals on the NSE and BSE.

Oxygenta Pharmaceutical Ltd (OXYGENTAPHLTD) is a micro-cap Healthcare company valued at ₹215 crore operating in Pharmaceuticals on the NSE and BSE.

Financial performance
Revenue has been growing strongly at 53.9% a year over three years. Return on equity is 41.2%.
Valuation multiples
A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -4.85 times book value.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.6/10
Weak
Fair Value
Sign in to see
ROE
41.16%
Strong
P/E
-15.20x
Loss-making
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

52W43.00
75.00
DocStoX take

Supported by growth (7.5), but held back by quality (2.2). Growth looks strong at 7.5, but that is offset by quality at 2.2. We are calling it Mixed rather than resolving the conflict for you. Scored on 3 of 5 measures.

DocStoX score

Low confidence
4.6
/10
Weak
Quality
Weak
ROE 41.2%
Valuation
No data
Loss-making — no meaningful P/E
Growth
Strong
Revenue +16.8% 5Y CAGR
Risk
Elevated
D/E 0.00
Momentum
No data
No technical indicators

Scored on 3 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹215 Cr
52W High / Low
₹75 / ₹43
Dividend Yield
0.00%
Promoter Holding
56.54%
EPS (TTM)
₹-4.75
Book Value

Key highlights

  • Strong returns on equity (41%)
  • Low leverage — D/E 0.00
  • Revenue compounding 17% a year
  • Loss-making — no meaningful P/E
  • Loss-making in some of the last 5 years
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Oxygenta Pharmaceutical Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.